136 related articles for article (PubMed ID: 24855987)
1. Ester groups as carriers of antivirally active tricyclic analogue of acyclovir in prodrugs designing: synthesis, lipophilicity--comparative statistical study of the chromatographic and theoretical methods, validation of the HPLC method.
Lesniewska MA; Ostrowski T; Zeidler J; Muszalska I
Comb Chem High Throughput Screen; 2014; 17(7):639-50. PubMed ID: 24855987
[TBL] [Abstract][Full Text] [Related]
2. Calculation procedures and HPLC method for analysis of the lipophilicity of acyclovir esters.
Lesniewska MA; Gdaniec Z; Muszalska I
Drug Dev Ind Pharm; 2015 Apr; 41(4):663-9. PubMed ID: 24580140
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic Derivative of Acyclovir and Its Esters in Relation to the Esters of Acyclovir Enzymatic Stability: Enzymatic Stability Study.
Muszalska-Kolos I; Lesniewska-Kowiel MA; Plewa S; Klupczyńska A
Molecules; 2020 May; 25(9):. PubMed ID: 32380673
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study.
Golankiewicz B; Ostrowski T; Goslinski T; Januszczyk P; Zeidler J; Baranowski D; de Clercq E
J Med Chem; 2001 Nov; 44(24):4284-7. PubMed ID: 11708929
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir.
Goslinski T; Golankiewicz B; De Clercq E; Balzarini J
J Med Chem; 2002 Nov; 45(23):5052-7. PubMed ID: 12408716
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2-amino-6-fluoro-9-(2-hydroxyethoxymethyl)purine esters as potential prodrugs of acyclovir.
Kim DK; Lee N; Im GJ; Kim HT; Kim KH
Bioorg Med Chem; 1998 Dec; 6(12):2525-30. PubMed ID: 9925308
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir.
Goslinski T; Wenska G; Golankiewicz B; Balzarini J; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):911-4. PubMed ID: 14565309
[TBL] [Abstract][Full Text] [Related]
8. New green synthesis and formulations of acyclovir prodrugs.
de Regil-Hernández R; Martínez-Lagos F; Rodríguez-Bayón A; Sinisterra JV
Chem Pharm Bull (Tokyo); 2011; 59(9):1089-93. PubMed ID: 21881250
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of acyclovir-5'-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug.
McGuigan C; Slater MJ; Parry NR; Perry A; Harris S
Bioorg Med Chem Lett; 2000 Apr; 10(7):645-7. PubMed ID: 10762044
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic analogues of acyclovir and ganciclovir. Influence of substituents in the heterocyclic moiety on the antiviral activity.
Golankiewicz B; Ostrowski T; Andrei G; Snoeck R; De Clercq E
J Med Chem; 1994 Sep; 37(19):3187-90. PubMed ID: 7932543
[TBL] [Abstract][Full Text] [Related]
11. HPLC and HPLC/MS/MS Studies on Stress, Accelerated and Intermediate Degradation Tests of Antivirally Active Tricyclic Analog of Acyclovir.
Lesniewska MA; Dereziński P; Klupczyńska A; Kokot ZJ; Ostrowski T; Zeidler J; Muszalska I
J AOAC Int; 2015; 98(5):1240-7. PubMed ID: 26525242
[TBL] [Abstract][Full Text] [Related]
12. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir.
Boryski J; Golankiewicz B; De Clercq E
J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016
[TBL] [Abstract][Full Text] [Related]
14. Controllable synthesis of polymerizable ester and amide prodrugs of acyclovir by enzyme in organic solvent.
Li X; Wu Q; Lv DS; Lin XF
Bioorg Med Chem; 2006 May; 14(10):3377-82. PubMed ID: 16431120
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and fluorescent properties of the tricyclic analogues of acyclovir linked with nitrogen hetbrocyclic units.
Goslinski T; Januszczyk P; Wenska G; Golankiewicz B; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):571-5. PubMed ID: 16247990
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic nucleoside analogues as antiherpes agents.
Golankiewicz B; Ostrowski T
Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
[TBL] [Abstract][Full Text] [Related]
18. Syntheses, chemical and enzymatic stability of new poly(ethylene glycol)-acyclovir prodrugs.
Zacchigna M; Di Luca G; Maurich V; Boccù E
Farmaco; 2002 Mar; 57(3):207-14. PubMed ID: 11989799
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
20. Anti-CyHV-3 Effect of Fluorescent, Tricyclic Derivative of Acyclovir 6-(4-MeOPh)-TACV
Troszok A; Kolek L; Szczygieł J; Ostrowski T; Adamek M; Irnazarow I
J Vet Res; 2019 Dec; 63(4):513-518. PubMed ID: 31934661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
